Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer
NCT03960788
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Cancer of the Prostate
Castration-resistant Prostate Cancer
Interventions
DRUG:
Gadoxetate Sodium
Sponsor
University of Cincinnati